Preemptive therapy of human herpesvirus-6 encephalitis with foscarnet sodium for high-risk patients after hematopoietic SCT
Authors:
Open Access
- 13 September 2010
- journal article
- clinical trial
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 46 (6) , 863-869
Abstract
Human herpesvirus-6 (HHV-6) is a major cause of limbic encephalitis with a dismal prognosis after allogeneic hematopoietic SCT (HSCT). A prospective, multicenter study was conducted to assess the safety and efficacy of preemptive therapy with foscarnet sodium (PFA) for the prevention of HHV-6 encephalitis. Plasma HHV-6 DNA was measured thrice weekly from day 7 until day 36 after umbilical cord blood transplantation (UCBT) or HSCT from HLA-haploidentical relatives. PFA, 90 mg/kg/day, was started when HHV-6 DNA exceeded 5 × 102 copies/mL. Mild and transient adverse events were associated with PFA in 7 of 8 patients. Twelve of 15 UCBT recipients became positive for HHV-6 DNAemia, defined by greater than 1 × 102 copies/mL of HHV-6 DNA in plasma. The virus exceeded 5 × 102 copies/mL in seven patients, whereas none of the five HLA-haploidentical HSCT recipients became positive. One patient developed mild limbic encephalitis just after initial PFA administration. Preemptive PFA therapy is safe, but as HHV-6 DNAemia can abruptly develop before neutrophil engraftment in UCBT recipients, prophylactic PFA administration from day 7 or earlier after UCBT may be needed.Keywords
This publication has 37 references indexed in Scilit:
- Reduced dose of foscarnet as preemptive therapy for cytomegalovirus infection following reduced‐intensity cord blood transplantationTransplant Infectious Disease, 2007
- Human Herpesvirus 6 DNA in Plasma after Allogeneic Stem Cell Transplantation: Incidence and Clinical SignificanceThe Journal of Infectious Diseases, 2006
- Clinical Outcomes of Human Herpesvirus 6 Reactivation after Hematopoietic Stem Cell TransplantationClinical Infectious Diseases, 2005
- Human herpesvirus 6 antigenaemia in allogeneic stem cell transplant recipients: impact on clinical course and association with other beta‐herpesvirusesBritish Journal of Haematology, 2004
- Analysis of immune reconstitution in children undergoing cord blood transplantationExperimental Hematology, 2001
- Monitoring four herpesviruses in unrelated cord blood transplantationBone Marrow Transplantation, 2000
- Human Herpesvirus 6 Infection after Autologous or Allogeneic Stem Cell Transplantation: A Single‐Center Prospective Longitudinal Study of 92 PatientsClinical Infectious Diseases, 2000
- Human Herpesvirus 6 Infections after Bone Marrow Transplantation: Clinical and Virologic ManifestationsThe Journal of Infectious Diseases, 1999
- Human Herpesvirus 6 Infection in Patients With Exanthema After Allogeneic Bone Marrow TransplantationArchives of Dermatology, 1998
- Detection of human herpesvirus‐6 DNA by polymerase chain reaction in serum or plasmaJournal of Medical Virology, 1992